After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...

Abstract: This article presents a 1.75-GS/s single-channel 7-bit successive approximation register (SAR) analog-to-digital converter (ADC) that is based on loop-unrolled architecture with ...

Abstract: The pipelined-SAR ADC has become popular in wide-bandwidth and high-resolution applications due to its power-efficient architecture [1]. In the pursuit of higher ADC speeds while maintaining ...